ISSN 1662-4009 (online)

ey0017.15-3 | (1) | ESPEYB17

15.3. An association between maternal weight change in the year before pregnancy and infant birth weight: ELFE, a French national birth cohort study

M Lecorguille , M Jacota , B de Lauzon-Guillain , A Forhan , M Cheminat , MA Charles , B Heude

To read the full abstract: PLoS Med. 2019 Aug 20;16(8):e1002871. doi: 10.1371/journal.pmed.1002871.Women (n =16,395; 26% overweight or obese) from the ELFE French national birth cohort were categorised into 3 groups by self-reported weight change during the year before pregnancy: weight loss >5 kg; stable weight; and weight gain >5 kg.Among women with B...

ey0018.10-2 | (1) | ESPEYB18

10.2. Impact of lockdown in COVID-19 on glycemic control in patients with type 1 diabetes mellitus

A Verma , R Rajput , S Verma , VKB Balania , B Jangra

Diabetes Metab Syndr. 2020;14(5):1213–1216. doi: 10.1016/j.dsx.2020.07.016In this small cross-sectional study on 52 pediactric patients with T1D, a structured questionnaire was administered on follow up within 15 days after lockdown during the COVID-19 pandemic. Of these 52 patients, 36.5% had hyperglycemic and 15.3% had hypoglycemic episodes. Insulin dose was missed in 26.9%, gluco...

ey0019.8-3 | New Mechanisms | ESPEYB19

8.3. DNA methylation signatures in human neonatal blood following maternal antenatal corticosteroid treatment

B Kim , S Sasaki , K Murphy , SG Matthews

Transl Psychiatry. 2022; 12(1): 132. PMID: 35354798https://pubmed.ncbi.nlm.nih.gov/35354798/Brief Summary: This case control study identified widespread effects of fetal exposure to antenatal maternal glucocorticoid treatment on newborn bloodspot DNA methylation profiles.Antenatal treatment with glucocorticoids (AGC), such as betamethasone or dexamethasone, is widely u...

ey0017.12-7 | Type 2 Diabetes | ESPEYB17

12.7. Dissecting racial bias in an algorithm used to manage the health of populations

Z Obermeyer , B Powers , C, et al. Vogeli

To read the full abstract: Science 2019;366(6464):447-53. doi: 10.1126/science.aax2342Short summary: Dissecting racial bias in health care systems revealed that a type of software program, which determines who receives access to high-risk health care management, routinely accepts healthier whites ahead of blacks who are less healthy.Comment: The yea...

ey0017.13-14 | Endocrinology | ESPEYB17

13.14. Newborn screening in Nigeria: Will incorporating congenital hypothyroidism with sickle cell disease improve neonatal screening programme?

EY Iroro , J Tamunopriye , B Datonye , I Lorenzo

To read the full abstract: Acta Biomed. 2019; 90(2): 316–320. doi: 10.23750/abm.v90i2.8485• The authors review the present status of newborn screening in Africa and discuss the concept that adding a neonatal screening for congenital hypothyroidism (CH) to an existing sickle cell disease screening would make it easier to implement than developing an independent screening program.&...

ey0017.14-6 | (1) | ESPEYB17

14.6. How frequently are articles in predatory open access journals cited

B-C Bjork , S Kanto-Karvonen , JT Harviainen

To read the full abstract: Publications 2020;8:17Predatory journals, sometimes called write-only publishing or deceptive publishing, follow an exploitive academic publishing business model that involves charging publication fees to authors without checking articles for quality and legitimacy and without providing the other editorial and publishing services that legitimate academic journals provide, whether open access or not. Their numbers keep ...

ey0015.6-10 | Food for thought | ESPEYB15

6.10 I am your trans patient

EB Lewis , B Vincent , A Brett , S Gibson , RJ Walsh

To read the full abstract: BMJ. 2017 Jun 30;357:j2963This group of 5 transgender and non-medical professional authors has written a unique “What Your Patient is Thinking” article published in the BMJ. Their aim was to tell health care providers, and others who manage transgender people, how they want to be received and treated and what went wrong in many previous meetings with the healt...

ey0017.4-10 | New perspectives | ESPEYB17

4.10. IGF-I in cord blood is predictive of final height in monozygotic twins with intratwin birth weight differences

C Kasner , S Schulte , F Schreiner , R Fimmers , B Stoffel-Wagner , P Bartmann , J Woelfle , B Gohlke

To read the full abstract: Clin Endocrinol (Oxf) 2020 May 13. doi: 10.1111/cen.14221. Online ahead of print.Children born either small for gestational age (SGA) or preterm usually do not achieve a final height (FH) in the mid-parental target height (MPTH) range, despite showing catch-up growth in the first years of life (1). The influence of intrauterine metabolic and hormonal factors has been p...

ey0016.5-2 | New Therapies and Novel Therapeutic Strategies | ESPEYB16

5.2. Humanin is a novel regulator of Hedgehog signaling and prevents glucocorticoid-induced bone growth impairment

F Zaman , Y Zhao , B Celvin , HH Mehta , J Wan , D Chrysis , C Ohlsson , B Fadeel , P Cohen , L Savendahl

Abstract: FASEB J. 2019;33:4962–4974.In brief: Glucocorticoid-induced growth impairment is reverted by the mitochondrial peptide humanin in dexamethasone-treated mice without attenuation of anti-inflammatory effects.Comment: Humanin (HN) is a 24 aminoacid peptide that was originally discovered as a neuroprotective factor and later shown ...

ey0016.10-17 | (1) | ESPEYB16

10.17. Relative prognostic importance and optimal levels of risk factors for mortality and cardiovascular outcomes in type 1 diabetes mellitus

A Rawshani , A Rawshani , N Sattar , S Franzen , DK McGuire , B Eliasson , AM Svensson , B Zethelius , M Miftaraj , A Rosengren , S Gudbjornsdottir

To read the full abstract: Circulation. 2019;139:1900–1912Numerous publications have reported that higher HbA1c levels relate to higher cardiovascular disease (CVD) risk in people with type 1 diabetes (T1D). However, the strength of association and optimal HbA1c levels are not established.This analysis of T1D patients recorded in the Swedish National Diabetes ...